The IPA Enlightenment Masterclass Series - Opportunities for antimicrobial photodynamic therapy
If you missed the live session, please see the IPA’s on demand videocasts and webinars.
Opportunities for antimicrobial photodynamic therapy
May 17, 2021 (9am US ET, 2pm GMT, 3pm CET)
Join the IPA for the second program of the Enlightenment Masterclass Series
Registration is free, but required.
Chairs: Pilar Acedo, University College London, UK and Anne-Laure Bulin, University Grenoble Alpes INSERM, France
In the context of the International Day of Light, the IPA will host a special edition of its masterclass series! On May 17th, a free virtual seminar will focus on antimicrobial Photodynamic Therapy (aPDT). It will cover topics such as antimicrobial resistance, current challenges and on-going aPDT clinical trials.
Program:
Introduction to Anitmicrobial PDT
Keith Cengel, MD, PhD - Associate Professor Radiation Oncology, University of Pennsylvania
An Introduction to Photodynamic Approach for Antimicrobial Applications: Some Examples
Amparo Faustino, PhD - Professor Department of Chemistry, University of Aveiro
Nowadays, Photodynamic Therapy (PDT) has been considered as a treatment modality for non-oncological situations like infections caused by microorganisms. The photodynamic action prompted by reactive oxygen species (ROS) occurs by combine of a sensitizing molecules (PS), visible light and dioxygen. Although the ability of a PS to generate ROS, namely singlet oxygen (1O2) is important for an efficient PDT effect, the structural feature of PS is another crucial aspect that is dependent on the target. Herein, will be discussed some examples antimicrobial applications of PDT.
PDT in Dentistry - Early Clinical Experience
Francesco d’Aiuto, DMD, PhD - Professor Periodontology, University College London
PDT in Infections
Kate Blanco, PhD - Researcher, University of São Paulo
From MRSA to COVID: present and future clinical applications in an otolaryngology surgical practice
Jack Kolenda, MD - Otolaryngologist, Head and Neck Surgeon, St. Joseph’s Health Centre in Toronto
Based on experiences in his own clinics, Dr. Kolenda will discuss the clinical uses of PDT for otolaryngologic inflammatory conditions and the possible utility of PDT in the treatment of early COVID-19.
Clinical Studies in Antimicrobial PDT
Nicolas Loebel, PhD - President and Chief Technology Officer, Ondine Biomedical
This talk will cover a decade of development of antimicrobial PDT into different clinical applications. The talk will focus on translational research aspects, and include regulatory and commercial issues which have been successfully addressed.